CDVA.CN stock dropped a sharp 44.44% to C$0.025 on 06 Mar 2026 during Canadian regular hours on the CNQ exchange. Trading volume surged to 42,424.00 shares versus an average of 7,375.00, signalling forced selling or a liquidity event. We review why CordovaCann Corp. (CDVA.CN) moved, how fundamentals and technicals line up, and what traders should watch next.

Market move and intraday volume for CDVA.CN stock

The intraday move shows an open at C$0.01 and a high of C$0.025 with a day low at C$0.01. Volume hit 42,424.00 shares, a relative volume of 5.75, far above the 50-day average of 7,375.00. High relative volume with a fall of -44.44% suggests directional conviction, likely from selling pressure or a headline hit. We link the trading spike to reduced liquidity and wider spreads on the CNQ market for micro-cap cannabis names.

Fundamentals and valuation snapshot for CDVA.CN stock

CordovaCann Corp. reports EPS -0.01 and a P/E of -2.50, reflecting negative earnings. Market capitalization stands at C$2,745,086.00, with 109,803,459.00 shares outstanding. Price averages are C$0.0282 (50-day) and C$0.04556 (200-day). Price-to-sales is 0.20, and price-to-free-cash-flow is 3.21, indicating cheap multiples but weak profitability. CurrentRatio is 0.18, flagging short-term liquidity stress. These metrics show valuation is low, but balance sheet and cash metrics raise funding risk.

Technical indicators and short-term trading signals for CDVA.CN stock

Technicals are mixed. RSI sits at 49.34, neutral. ADX is 28.57, indicating a strong trend in place. Bollinger middle band is C$0.02 and ATR is C$0.01, showing elevated volatility. Price sits below the 50-day average but near its day high, reflecting intra-session recovery attempts. Short-term traders should watch support at C$0.01 and resistance at C$0.03, with order book depth thin on CNQ.

Meyka AI grade, analyst context and CDVA.CN stock analysis

Meyka AI rates CDVA.CN with a score of 76.00 out of 100, Grade B+, suggestion BUY. This grade factors S&P 500 and sector comparisons, industry metrics, financial growth, key ratios, forecasts, and analyst consensus. The broader company rating on 03 Mar 2026 was C with a sell recommendation from another provider, highlighting divergent views. We present the Meyka grade as an analytical snapshot, not investment advice.

Risks, catalysts and sector context for CDVA.CN stock

CordovaCann operates in Healthcare, Drug Manufacturers – Specialty & Generic, a sector under pressure and with average performance down -0.69% YTD. Key risks include low current ratio (0.18), negative EPS, and dependence on retail operations in Canada and the U.S. Catalysts include funding events, same-store sales improvements at Star Buds, or regulatory clarity. Any positive operational update could sharply alter price given thin liquidity.

Short-term price levels and practical trading checklist for CDVA.CN stock

Immediate support: C$0.01. Short-term resistance: C$0.03 and C$0.04. Stop-loss discipline is essential due to high volatility and low liquidity. Monitor volume spikes above 7,375.00 average to confirm moves. For portfolio managers, treat CDVA.CN as a high-risk micro-cap position and size accordingly.

Final Thoughts

Key takeaways for CDVA.CN stock: the share price plunged -44.44% to C$0.025 on 06 Mar 2026 with unusually high volume of 42,424.00 shares. Fundamentals show negative EPS -0.01, a P/E of -2.50, and tight liquidity with a current ratio of 0.18. Meyka AI’s forecast model projects a monthly level of C$0.04 and a quarterly level of C$0.03. Versus the current price C$0.025, the monthly forecast implies 60.00% upside and the quarterly forecast implies 20.00% upside. Forecasts are model-based projections and not guarantees. Given the thin order book on CNQ and sector headwinds in healthcare cannabis retail, traders should expect heightened volatility. We track news flow, funding updates, and same-store sales as potential triggers. For more on live quotes and updated metrics visit the Meyka AI stock page for CDVA.CN and check the recent market comparison at Investing.com. Meyka AI provides this data as an AI-powered market analysis platform, not financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.